{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:58:54Z","timestamp":1790665134683,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"DOI":"10.1007\/s00198-026-08229-6","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:18:07Z","timestamp":1790662687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decreased incidence of shoulder arthroplasty in patients prescribed anti-resorptive therapy for osteoporosis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7446-0064","authenticated-orcid":false,"given":"Tarek","family":"Haj Shehadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"El Zeini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Elzomor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Updegrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3641-9367","authenticated-orcid":false,"given":"Nathan","family":"Lanham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"8229_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10192","volume":"3","author":"EM Lewiecki","year":"2019","unstructured":"Lewiecki EM, Ortendahl JD, Vanderpuye-Orgle J, Grauer A, Arellano J, Lemay J, Harmon AL, Broder MS, Singer AJ (2019) Healthcare policy changes in osteoporosis can improve outcomes and reduce costs in the United States. JBMR 3:e10192 https:\/\/doi.org\/10.1002\/jbm4.10192","journal-title":"JBMR"},{"key":"8229_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/370231","volume":"2013","author":"C Chillemi","year":"2013","unstructured":"Chillemi C, Franceschini V (2013) Shoulder osteoarthritis. Arthritis 2013:370231. https:\/\/doi.org\/10.1155\/2013\/370231","journal-title":"Arthritis"},{"key":"8229_CR3","doi-asserted-by":"publisher","first-page":"8769","DOI":"10.3390\/jcm14248769","volume":"14","author":"RMY Wong","year":"2025","unstructured":"Wong RMY, Wong PY, Lee JK, Unnanuntana A, Amphansap T, Ebeling PR, Close J, Duque G, Law SW, Cheung WH (2025) High Prevalence of osteopenia and osteoporosis in total hip and total knee arthroplasty patients and effects of anti-resorptive agents on bone health optimization: a systematic review and meta-analysis. J Clin Med 14:8769 https:\/\/doi.org\/10.3390\/jcm14248769","journal-title":"J Clin Med"},{"key":"8229_CR4","unstructured":"Sen R, Hurley JA (2026) Osteoarthritis In: StatPearls StatPearls Publishing, Treasure Island (FL)"},{"key":"8229_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jse.2010.05.006","volume":"20","author":"R Bartelt","year":"2011","unstructured":"Bartelt R, Sperling JW, Schleck CD, Cofield RH (2011) Shoulder arthroplasty in patients aged 55 years or younger with osteoarthritis. J Shoulder Elb Surg 20:123\u2013130 https:\/\/doi.org\/10.1016\/j.jse.2010.05.006","journal-title":"J Shoulder Elb Surg"},{"key":"8229_CR6","unstructured":"Ganesan K, Goyal A, Roane D (2026) Bisphosphonate In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"8229_CR7","unstructured":"Hildebrand GK, Patel P, Kasi A (2026) Denosumab In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"8229_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12325-021-01936-y","volume":"39","author":"DL Kendler","year":"2022","unstructured":"Kendler DL, Cosman F, Stad RK, Ferrari S (2022) Denosumab in the treatment of osteoporosis: 10 years later: a narrative review. Adv Ther 39:58\u201374 https:\/\/doi.org\/10.1007\/s12325-021-01936-y","journal-title":"Adv Ther"},{"key":"8229_CR9","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2106\/JBJS.16.00385","volume":"99","author":"SH Fu","year":"2017","unstructured":"Fu SH, Wang CY, Yang RS, Wu FL, Hsiao FY (2017) Bisphosphonate use and the risk of undergoing total knee arthroplasty in osteoporotic patients with osteoarthritis: a nationwide cohort study in Taiwan. J Bone Jt Surg Am 99:938\u2013946. https:\/\/doi.org\/10.2106\/JBJS.16.00385","journal-title":"J Bone Jt Surg Am"},{"key":"8229_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/annrheumdis-2017-211811","volume":"77","author":"T Neogi","year":"2018","unstructured":"Neogi T, Li S, Peloquin C, Misra D, Zhang Y (2018) Effect of bisphosphonates on knee replacement surgery. Ann Rheum Dis 77:92\u201397 https:\/\/doi.org\/10.1136\/annrheumdis-2017-211811","journal-title":"Ann Rheum Dis"},{"key":"8229_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.588095","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhu J, Zhou Y, Peng J, Wang B (2021) Efficacy and safety of denosumab in osteoporosis or low bone mineral density postmenopausal women. Front Pharm 12:588095 https:\/\/doi.org\/10.3389\/fphar.2021.588095","journal-title":"Front Pharm"},{"key":"8229_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.799575","volume":"12","author":"Q Hu","year":"2021","unstructured":"Hu Q, Zhong X, Tian H, Liao P (2021) The efficacy of denosumab in patients with rheumatoid arthritis: a systematic review and pooled analysis of randomized or matched data. Front Immunol 12:799575 https:\/\/doi.org\/10.3389\/fimmu.2021.799575","journal-title":"Front Immunol"},{"key":"8229_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00774-020-01159-1","volume":"39","author":"S Tanaka","year":"2021","unstructured":"Tanaka S, Tanaka Y (2021) RANKL as a therapeutic target of rheumatoid arthritis. J Bone Min Metab 39:106\u2013112 https:\/\/doi.org\/10.1007\/s00774-020-01159-1","journal-title":"J Bone Min Metab"},{"key":"8229_CR14","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.joca.2026.01.001","volume":"34","author":"Z Zhu","year":"2026","unstructured":"Zhu Z, Huang JY, Wang W, Liu S, Zhang H, Wang Q, Fu K, Ding C, Wei JC, Hunter DJ (2026) Association between denosumab use and risk of osteoarthritis among adults with osteoporosis in a real-world cohort. Osteoarthr Cartil 34:1270\u20131280 https:\/\/doi.org\/10.1016\/j.joca.2026.01.001","journal-title":"Osteoarthr Cartil"},{"key":"8229_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.reth.2024.03.019","volume":"27","author":"L Shangguan","year":"2024","unstructured":"Shangguan L, Ding M, Wang Y, Xu H, Liao B (2024) Denosumab ameliorates osteoarthritis by protecting cartilage against degradation and modulating subchondral bone remodeling. Regen Ther 27:181\u2013190 https:\/\/doi.org\/10.1016\/j.reth.2024.03.019","journal-title":"Regen Ther"},{"key":"8229_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-66202-z","volume":"16","author":"Y Hu","year":"2025","unstructured":"Hu Y, Chen W, Lan S, Ming C, Xu D, Li H, Xu H, Shi D, Liu W, Dai Z, Wang J, He Z, Xu W, Shao Z, Liu Y, Tian H, Tong W (2025) Denosumab attenuates knee osteoarthritis progression by inhibiting synovial inflammation via the RANK\/TRAF6\/FSTL1 signalling. Nat Commun 16:11394 https:\/\/doi.org\/10.1038\/s41467-025-66202-z","journal-title":"Nat Commun"},{"key":"8229_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40266-021-00916-9","volume":"39","author":"OA Al-Mohrej","year":"2022","unstructured":"Al-Mohrej OA, Prada C, Leroux T, Shanthanna H, Khan M (2022) Pharmacological treatment in the management of glenohumeral osteoarthritis. Drugs Aging 39:119\u2013128 https:\/\/doi.org\/10.1007\/s40266-021-00916-9","journal-title":"Drugs Aging"},{"key":"8229_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11926-003-0085-6","volume":"5","author":"AA Reszka","year":"2003","unstructured":"Reszka AA, Rodan GA (2003) Bisphosphonate mechanism of action. Curr Rheumatol Rep 5:65\u201374 https:\/\/doi.org\/10.1007\/s11926-003-0085-6","journal-title":"Curr Rheumatol Rep"},{"key":"8229_CR19","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/ijcp.12022","volume":"66","author":"DA Hanley","year":"2012","unstructured":"Hanley DA, Adachi JD, Bell A, Brown V (2012) Denosumab: mechanism of action and clinical outcomes. Int J Clin Pract 66:1139\u20131146 https:\/\/doi.org\/10.1111\/ijcp.12022","journal-title":"Int J Clin Pract"},{"key":"8229_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115352","volume":"143","author":"EF Eriksen","year":"2021","unstructured":"Eriksen EF, Shabestari M, Ghouri A, Conaghan PG (2021) Bisphosphonates as a treatment modality in osteoarthritis. Bone 143:115352 https:\/\/doi.org\/10.1016\/j.bone.2020.115352","journal-title":"Bone"},{"key":"8229_CR21","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/medicina58091207","volume":"58","author":"BN Stamenkovic","year":"2022","unstructured":"Stamenkovic BN, Rancic NK, Bojanovic MR, Stojanovic SK, Zivkovic VG, Djordjevic DB, Stankovic AM (2022) Is osteoarthritis always associated with low bone mineral density in elderly patients? Medicina 58:1207 https:\/\/doi.org\/10.3390\/medicina58091207","journal-title":"Medicina"},{"key":"8229_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41413-021-00147-z","volume":"9","author":"Y Hu","year":"2021","unstructured":"Hu Y, Chen X, Wang S, Jing Y, Su J (2021) Subchondral bone microenvironment in osteoarthritis and pain. Bone Res 9:20 https:\/\/doi.org\/10.1038\/s41413-021-00147-z","journal-title":"Bone Res"},{"key":"8229_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.joca.2020.05.006","volume":"28","author":"MC Nevitt","year":"2020","unstructured":"Nevitt MC, Felson DT (2020) High bone density and radiographic osteoarthritis: questions answered and unanswered. Osteoarthr Cartil 28:1151\u20131153 https:\/\/doi.org\/10.1016\/j.joca.2020.05.006","journal-title":"Osteoarthr Cartil"},{"key":"8229_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jbmr.3909","volume":"35","author":"L Chu","year":"2020","unstructured":"Chu L, Liu X, He Z, Han X, Yan M, Qu X, Li X, Yu Z (2020) Articular cartilage degradation and aberrant subchondral bone remodeling in patients with osteoarthritis and osteoporosis. J Bone Min Res 35:505\u2013515 https:\/\/doi.org\/10.1002\/jbmr.3909","journal-title":"J Bone Min Res"},{"key":"8229_CR25","doi-asserted-by":"publisher","first-page":"e007568","DOI":"10.1136\/bmjopen-2014-007568","volume":"5","author":"H Zheng","year":"2015","unstructured":"Zheng H, Chen C (2015) Body mass index and risk of knee osteoarthritis: systematic review and meta-analysis of prospective studies. BMJ Open 5:e007568 https:\/\/doi.org\/10.1136\/bmjopen-2014-007568","journal-title":"BMJ Open"},{"key":"8229_CR26","doi-asserted-by":"publisher","first-page":"R625","DOI":"10.1186\/ar1716","volume":"7","author":"TD Spector","year":"2005","unstructured":"Spector TD, Conaghan PG, Buckland-Wright JC, Garnero P, Cline GA, Beary JF, Valent DJ, Meyer JM (2005) Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173. Arthritis Res Ther 7:R625\u2013R633 https:\/\/doi.org\/10.1186\/ar1716","journal-title":"Arthritis Res Ther"},{"key":"8229_CR27","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1001\/jama.2020.2938","volume":"323","author":"G Cai","year":"2020","unstructured":"Cai G, Aitken D, Laslett LL, Pelletier JP, Martel-Pelletier J, Hill C, March L, Wluka AE, Wang Y, Antony B, Blizzard L, Winzenberg T, Cicuttini F, Jones G (2020) Effect of intravenous zoledronic acid on tibiofemoral cartilage volume among patients with knee osteoarthritis with bone marrow lesions: a randomized clinical trial. JAMA 323:1456\u20131466 https:\/\/doi.org\/10.1001\/jama.2020.2938","journal-title":"JAMA"},{"key":"8229_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.joca.2017.11.013","volume":"26","author":"EE Vaysbrot","year":"2018","unstructured":"Vaysbrot EE, Osani MC, Musetti MC, McAlindon TE, Bannuru RR (2018) Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials. Osteoarthr Cartil 26:154\u2013164 https:\/\/doi.org\/10.1016\/j.joca.2017.11.013","journal-title":"Osteoarthr Cartil"},{"key":"8229_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41591-024-02822-0","volume":"30","author":"R Wittoek","year":"2024","unstructured":"Wittoek R, Verbruggen G, Vanhaverbeke T, Colman R, Elewaut D (2024) RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial. Nat Med 30:829\u2013836 https:\/\/doi.org\/10.1038\/s41591-024-02822-0","journal-title":"Nat Med"},{"key":"8229_CR30","unstructured":"Gold, M, Munjal, A, Varacallo, MA (2026) Anatomy, bony pelvis and lower limb, hip joint. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"8229_CR31","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.jbiomech.2006.10.016","volume":"40","author":"HE Veeger","year":"2007","unstructured":"Veeger HE, van der Helm FC (2007) Shoulder function: the perfect compromise between mobility and stability. J Biomech 40:2119\u20132129 https:\/\/doi.org\/10.1016\/j.jbiomech.2006.10.016","journal-title":"J Biomech"},{"key":"8229_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jbspin.2010.04.011","volume":"78","author":"L Jiang","year":"2011","unstructured":"Jiang L, Rong J, Wang Y, Hu F, Bao C, Li X, Zhao Y (2011) The relationship between body mass index and hip osteoarthritis: a systematic review and meta-analysis. Jt Bone Spine 78:150\u2013155 https:\/\/doi.org\/10.1016\/j.jbspin.2010.04.011","journal-title":"Jt Bone Spine"},{"key":"8229_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jisako.2023.06.002","volume":"8","author":"N Yamamoto","year":"2023","unstructured":"Yamamoto N, Szymski D, Voss A, Ishikawa H, Muraki T, Cunha RA, Ejnisman B, Noack J, McCarty E, Mulcahey MK, Itoi E (2023) Non-operative management of shoulder osteoarthritis: current concepts. J ISAKOS 8:289\u2013295 https:\/\/doi.org\/10.1016\/j.jisako.2023.06.002","journal-title":"J ISAKOS"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08229-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08229-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08229-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:18:09Z","timestamp":1790662689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-026-08229-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":33,"alternative-id":["8229"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08229-6","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"13 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was IRB approval exempt since only de-identified patient data was accessed.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Human Ethics and Consent to Participate declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":3,"name":"Ethics","label":"Consent\/Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tarek Haj Shehadeh, Mustapha\u00a0El Zeini, Tarek Elzomor, Yusuf Rashid, Gary Updegrove\u00a0and Nathan Lanham declare that they have no conflict of interest.","order":4,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}